Mankind Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹3,442.93 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.48 per cent from ₹3,567.20 crore. This corresponds to a year-on-year *(YoY) growth of 11.81 per cent.
Operating Profit
Operating Profit stands at ₹906.72 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.55 per cent from ₹812.84 crore. This corresponds to a year-on-year *(YoY) growth of 33.57 per cent.
PBDT
PBDT stands at ₹882.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.59 per cent from ₹731.60 crore. This corresponds to a year-on-year *(YoY) growth of 18.91 per cent.
Profit Before Tax
Profit Before Tax stands at ₹659.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.50 per cent from ₹509.00 crore. This corresponds to a year-on-year *(YoY) growth of 28.97 per cent.
Net Profit
Net Profit stands at ₹559.42 crore, reflecting a quarter-on-quarter *(QoQ) increase of 35.16 per cent from ₹413.88 crore. This represents a 31.74 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Mankind Pharma Ltd News
Mankind Pharma Ltd Earnings
- YOY
- QOQ
Mankind Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Mankind Pharma Ltd Research Reports
Mankind Pharma Ltd Financial Reports
Mankind Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Mankind Pharma | -0.66% | -0.61% | 6.06% | 21.42% | 14.09% | -6.48% |
| Cipla | -0.20% | -2.21% | 4.14% | 18.78% | -0.61% | -3.09% |
| Zydus Lifesci. | -0.81% | 0.21% | 5.77% | 24.63% | 27.80% | 18.79% |
| Lupin | -0.35% | 0.14% | 9.79% | 7.94% | 14.67% | 29.68% |
| Dr Reddy's Labs | -1.91% | -9.00% | -2.64% | 0.83% | 4.63% | -0.44% |
| Aurobindo Pharma | -1.00% | -1.84% | 11.20% | 16.80% | 34.07% | 37.39% |
| Laurus Labs | 2.33% | 0.59% | 10.72% | 41.39% | 45.50% | 86.64% |
Company Info
Company Information
Chairman & Wholetime Director : RAMESH CHAND JUNEJA
Vice Chairman & Managing Director : RAJEEV JUNEJA
Whole Time Director & Chief Executive Officer : SHEETAL ARORA
Independent Director : TILOKCHAND PUNAMCHAND OSTWAL
Independent Director : Bharat Anand
Whole-time Director : SATISH KUMAR SHARMA
Independent Director : Vivek Kalra
Independent Director : Vijaya Sampath
Company Sec. & Compli. Officer : Hitesh Kumar Jain